UBS Group »

Aardvark Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $352k 27k 13.13
2025-09-30 $727k 55k 13.29
2025-06-30 $702k 52k 13.52
2025-03-31 $110k 15k 7.51